Evidence map›Paper›PMID 38854305›Full record

ArticleCureus2024

Inhibition of Cholesteryl Ester Transfer Protein Contributes to the Protection of Ginsenoside Re Against Isoproterenol-Induced Cardiac Hypertrophy.

Yumei Qiu, Mengdie Xie, Xiaoyun Ding, Hao Zhang, Hongming Li, Hu Wang, Tingting Li, Wei Dong, Fangqin Jiang, Xilan Tang

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yumei QiuSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Mengdie XieSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Xiaoyun DingSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Hao ZhangSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Hongming LiSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Hu WangSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Tingting LiSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Wei DongKey Laboratory of Modern Preparation of Chinese Medicine, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, CHN.
Fangqin JiangSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.
Xilan TangSchool of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, CHN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives Ginsenoside Re (Re), a protopanaxatriol-type saponin extracted from ginseng, is known to have potential cardioprotective effects; however, the mechanisms of Re in improving cardiac hypertrophy have not been fully elucidated. This study aimed to investigate the therapeutic effects and underlying mechanism of Re on isoproterenol (ISO)-induced cardiac hypertrophy

Indexed as

cardiac hypertrophycholesteryl ester transfer proteinginsenoside rehigh-density lipoprotein cholesterolisoproterenol

Identifiers

PMID38854305
PMCPMC11161854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.